Evan Guillemin - 01 Sep 2022 Form 4 Insider Report for MESA LABORATORIES INC /CO/ (MLAB)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
02 Sep 2022, 12:24:58 UTC
Prior SEC filing
19 Aug 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
John Sakys under Power of Attorney by Evan Guillemin

Key filing fact

Evan Guillemin filed Form 4 for MESA LABORATORIES INC /CO/ (MLAB) on 02 Sep 2022.

Key facts

  • This page summarizes Evan Guillemin's Form 4 filing for MESA LABORATORIES INC /CO/ (MLAB).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 02 Sep 2022, 12:24.

Change

  • Previous filing in this sequence was filed on 19 Aug 2022.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MLAB transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+431
Change %
+1.5%
Price
$0.000000
Shares after
29,207
Date
01 Sep 2022
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MLAB transaction Derivative

Restricted Stock Units - 6

Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities

Transaction value
$0
Shares
-431
Change %
-100%
Price
$0.000000*
Shares after
0
Date
01 Sep 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
431
Exercise price
Footnotes
F1, F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each RSU represents a contingent right to receive one share of the Issuer's common stock

Footnote F2

Vested RSUs for Board of Director services

Footnote F3

Not applicable

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .